These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 405803)

  • 1. Obstetrical management of Rh negative pregnancies.
    Henderson PA
    Wis Med J; 1977 May; 76(5):77-8. PubMed ID: 405803
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoprophylaxis of neonatal hemolytic disease caused by Rh incompatibility. Analysis of a 5-year experience].
    Sansone G; Veneziano G; Mantegazza F; Cominetti M
    Pathologica; 1974; 66(961-962):477-89. PubMed ID: 4141760
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention and treatment of Rh. isoimmunization. Results].
    Martínez M; Lozano G; Flores F; Fernández P; Garrido G
    Acta Obstet Ginecol Hisp Lusit; 1971 Mar; 19(2):149-57. PubMed ID: 4996734
    [No Abstract]   [Full Text] [Related]  

  • 4. [Systematic immunization in pregnancy].
    Simonetti N
    Minerva Ginecol; 1972 Feb; 24(2):98-9. PubMed ID: 4211684
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of post-partum Rh-factor isoimmunization (experience of the Hospital 1st Gynecological-Obstetrical of the Mexican Institute of Social Security)].
    Cepeda AG; Sentíes L; Fiorelli FE; Garcete JA
    Ginecol Obstet Mex; 1975 Feb; 37(220):83-91. PubMed ID: 804430
    [No Abstract]   [Full Text] [Related]  

  • 6. [Selective Rh prevention in pregnancy].
    Helderweirt G
    Verh K Acad Geneeskd Belg; 1983; 45(3):261-74. PubMed ID: 6421025
    [No Abstract]   [Full Text] [Related]  

  • 7. Rh prevention: a report and analysis of a national programme.
    Eklund J; Nevanlinna HR
    J Med Genet; 1973 Mar; 10(1):1-7. PubMed ID: 4633302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preliminary clinical experiences with immunosuppressive agents in prenatal treatment of Rh isoimmunization].
    Viozzi A; Gasparini G; Cagliari P
    Minerva Ginecol; 1970 May; 22(9):462-3. PubMed ID: 4995416
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of failures in the prevention of Rh incompatibility].
    Seyfriedowa H; Lenkiewicz B; Dyl P
    Ginekol Pol; 1985; 56(5-6):335-41. PubMed ID: 3932136
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prospects of the clinical use of immunosuppressive agents in control of materno-fetal Rh isoimmunization and in attempted prevention. (Theoretical presuppositions and preliminary clinical experiences)].
    Vecchietti G; Onnis A
    Minerva Ginecol; 1970 May; 22(9):459-62. PubMed ID: 4995415
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of leukocytic isosensitization in pregnancy on the condition of the newborn infant].
    Kuznechikova VV; Vasil'eva ZF; Poliakova GP
    Vopr Okhr Materin Det; 1971 Jan; 16(1):40-5. PubMed ID: 4995798
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis of the temporal trend of antibody titer after delivery in subjects with anti-Rh (D) isoimmunization].
    Mattone PG; Meriggi E; Sanlorenzo F; Gagliardi L
    Ann Ostet Ginecol Med Perinat; 1973 May; 94(5):351-60. PubMed ID: 4215361
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rhesus sensitization and prevention with anti-D-immunoglobulin].
    Hindemann P; Hinselmann M; Frey P
    Gynaecologia; 1969; 167(5):276-9. PubMed ID: 4184763
    [No Abstract]   [Full Text] [Related]  

  • 15. [Incidence of erythroblastosis in the umbilical cord blood of newborn infants with materno-fetal Rh factor incompatibility without signs of isoimmunization].
    Moscatelli P; Pantarotto F; Melevendi C
    Minerva Pediatr; 1967 Oct; 19(43):1901-2. PubMed ID: 4974603
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with prophylactic serological examinations of expectant mothers].
    Bösenberg M
    Dtsch Med Wochenschr; 1966 Dec; 91(49):2202-5. PubMed ID: 4959062
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemolytic disease of the newborn due to combination of anti-E and anti-S in the first pregnancy.
    Kanra T; Tunçer M; Pirnar A
    Turk J Pediatr; 1983; 25(1):49-54. PubMed ID: 6417855
    [No Abstract]   [Full Text] [Related]  

  • 18. [Partial replacement of blood transfusions as a method of reducing RH-sensitization in obstetrical practice].
    Vasil'eva ZF; Matveeva OF; Kuznechikova VV; Anichkova SI
    Vopr Okhr Materin Det; 1971 Oct; 16(10):64-7. PubMed ID: 5001887
    [No Abstract]   [Full Text] [Related]  

  • 19. Remaining problems in the prevention of Rh0 isoimmunization.
    Goplerud CP
    Semin Perinatol; 1977 Apr; 1(2):177-81. PubMed ID: 89700
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immuno-hematology of obstetrical importance. (Technical notes)].
    Furfaro M
    Minerva Ginecol; 1970 Jan; 22(1):31-47. PubMed ID: 4987993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.